Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study
Authors:
- A. FarolfiAFA. Farolfi
- L. RidolfiL. Ridolfi
- M. GuidoboniMGM. Guidoboni
- C. MilandriCMC. Milandri
- F. CalzolariFCF. Calzolari
- E. ScarpiESE. Scarpi
- D. AmadoriDAD. Amadori
- R. RidolfiRRR. Ridolfi
- 1 October 2011
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 23 (5) , 300-305
Abstract
The liver is the primary site of metastases in most uveal melanoma patients. We retrospectively investigated intraarterial chemotherapy (IAC) as treatment for patients with hepatic melanoma metastases. Twenty-three patients (18 with uveal melanoma) received fotemustine (14 patients, 61.9%) or carboplatin (9 patients, 31.1%) via hepatic IAC delivery. The catheter was introduced through percutaneous access to the femoral artery with drugs delivered directly to the hepatic artery, and was removed at the end of each treatment cycle. A total of 3 cycles was planned, repeated every 21 days. However, patients with a clinical response could receive more than 3 cycles, provided that the toxic effects were acceptable. IAC was well tolerated and no catheter-related complications or grade 4 toxicities were reported. Considering only uveal melanoma patients, the overall response rate and disease control rate was 16.7% and 38.9%, respectively. Median time to progression was 6.2 months (95% CI 3.7-10.5) and median overall survival was 21 months (95% CI 8-39). IAC is well tolerated and is a valid choice for patients with a poor prognosis since median survival rates are among the longest reported.Keywords
This publication has 27 references indexed in Scilit:
- Systematic Review of Medical Treatment in Melanoma: Current Status and Future ProspectsThe Oncologist, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Locoregional Management of Hepatic Metastasis From Primary Uveal MelanomaSeminars in Oncology, 2010
- Anti-CTLA-4 therapy in melanoma: role of ipilimumab (MDX-010)Expert Review of Dermatology, 2009
- Molecular Pathways Mediating Liver Metastasis in Patients with Uveal MelanomaClinical Cancer Research, 2008
- Treatment of Melanoma Metastases Confined to the Liver and Future PerspectivesDigestive Surgery, 2008
- Variates of Survival in Metastatic Uveal MelanomaJournal of Clinical Oncology, 2005
- Independent prognostic factors for distant metastases and survival in patients with primary uveal melanomaEuropean Journal of Cancer, 2004
- Screening for Metastasis From Choroidal Melanoma: The Collaborative Ocular Melanoma Study Group Report 23Journal of Clinical Oncology, 2004
- A prognostic model and staging for metastatic uveal melanomaCancer, 2003